Avalo Therapeutics Inc (AVTX)

NASDAQ · Biotechnology

19.20
-0.14 (-0.72%)
Updated Sep 1, 7:01 PM ET
AI Rating
Buy
Overall Score
71
Trend
100
Momentum
53
Risk
50

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 19, 2025 260 sessions Aug 31, 2026

AI Analysis

Avalo Therapeutics Inc is trading at $19.20, down 0.72% on the session. The 50 day average sits at $19.00 and the 200 day at $16.85, which puts the stock in a uptrend. RSI is at 49.9, which reads as neutral, and MACD is bearish crossover. Volume is volume spike.

The nearest support is around $18.88 with resistance near $19.83, so that band frames the current range. Average daily movement is roughly $1.00, or about 5.2% of the share price, which is what any stop placement has to allow for. The overall health score of 71 out of 100 combines a trend score of 100, momentum of 53 and a risk score of 50.

Technical indicators

RSI (14)
49.9
neutral
MACD
0.317
bearish crossover
SMA 20
19.54
SMA 50
19.00
SMA 200
16.85
uptrend
ATR (14)
1.00
avg daily range
Support
18.88
Resistance
19.83
Volume vs 20d
1.93x
volume spike
Volatility
47.3%
annualised
1 month
+5.97%
3 months
+22.79%

AI trade signals on AVTX

All signals
Date Setup Entry Target Stop R:R Status
Aug 20 Breakout ••.•• ••.•• ••.•• 1.61:1 Expired

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.